Komori
Revision of earnings forecasts4202Daicel CorporationMaterials and Chemicals

Consolidated Financial Results for the Fiscal Year Ending March 2026 (Japanese GAAP)

The company announced its consolidated results for the fiscal year ended March 2026. Revenue, operating income, ordinary income and net income all declined year on year. For the fiscal year ending March 2027, the company expects increases in revenue, operating income and net income, while forecasting a decline in ordinary income. The dividend forecast is scheduled to be announced on 22 May 2026.

Worth reading
76Important
Scored from 4 of 5 sections
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Conditional
How definitive the wording is.

Revised forecast

Fiscal year ending March 2027 · Six months and full year
Net Sales—→—million
—
Operating profit—→—million
—
Ordinary income—→—million
—
Profit attributable to owners of the parent—→—million
—
Net income per share—→—yen
—

The bar length represents the relative magnitude of change, based on the item that changed the most in this document.

Reason for the revision

The company expects revenue to increase due to higher sales volumes of engineering plastics and inflators for automotive airbags, among other factors. Operating income is expected to increase slightly due to lower sales prices for acetate tow and higher pulp prices, among other factors. Ordinary income is expected to decline due to lower dividend income associated with the sale of strategically held shares and lower equity in earnings of affiliates. Net income attributable to owners of the parent is expected to increase due to the absence of the impairment losses recorded in the previous fiscal year.

Details and amount of extraordinary loss

Impairment losses of ¥32,845 million and total extraordinary losses of ¥38,991 million. The impairment losses primarily comprised ¥30,682 million related to engineering plastics manufacturing facilities and ¥419 million related to manufacturing facilities for automotive airbag initiators, among other items.

Previous-period resultsFiscal year ended March 2026 results: revenue of ¥579,629 million, operating income of ¥42,069 million, ordinary income of ¥45,130 million, net income attributable to owners of the parent of ¥10,180 million, and basic earnings per share of ¥38.75
Dividend forecast revisionThe dividend forecast for the fiscal year ending March 2027 remains undecided and is scheduled to be announced on 22 May 2026 together with the new medium-term strategy.
Consolidated / non-consolidatedConsolidated
Revised forecast
ItemDetails
Net SalesNot disclosed → Cumulative second-quarter results 288,000 / Full year 595,000
Operating profitNot disclosed → Cumulative second-quarter results 16,500 / Full year 42,500
Ordinary incomeNot disclosed → Cumulative second-quarter results 17,000 / Full year 43,000
Profit attributable to owners of the parentNot disclosed → Cumulative second-quarter results 10,000 / Full year 32,000
Net income per shareNot disclosed → Cumulative second-quarter results 39.16 / Full year 125.3
Fiscal Period CoveredFiscal year ending March 2027
Period CoveredSix months and full year
Previous-period resultsFiscal year ended March 2026 results: revenue of ¥579,629 million, operating income of ¥42,069 million, ordinary income of ¥45,130 million, net income attributable to owners of the parent of ¥10,180 million, and basic earnings per share of ¥38.75
Reason for the revisionThe company expects revenue to increase due to higher sales volumes of engineering plastics and inflators for automotive airbags, among other factors. Operating income is expected to increase slightly due to lower sales prices for acetate tow and higher pulp prices, among other factors. Ordinary income is expected to decline due to lower dividend income associated with the sale of strategically held shares and lower equity in earnings of affiliates. Net income attributable to owners of the parent is expected to increase due to the absence of the impairment losses recorded in the previous fiscal year.
Details and amount of extraordinary lossImpairment losses of ¥32,845 million and total extraordinary losses of ¥38,991 million. The impairment losses primarily comprised ¥30,682 million related to engineering plastics manufacturing facilities and ¥419 million related to manufacturing facilities for automotive airbag initiators, among other items.
Dividend forecast revisionThe dividend forecast for the fiscal year ending March 2027 remains undecided and is scheduled to be announced on 22 May 2026 together with the new medium-term strategy.
Consolidated / non-consolidatedConsolidated
Items this document does not state (1)
Publication date of previous forecast

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

For the fiscal year ended March 2026, net income declined sharply due to impairment losses arising from delays in demand expansion and increased investment, among other factors. For the fiscal year ending March 2027, the company expects sales volume increases for engineering plastics and inflators for automotive airbags, while also anticipating lower sales prices for acetate tow, higher pulp prices, lower dividend income associated with the sale of strategically held shares, and lower equity in earnings of affiliates, among other factors.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Consolidated Financial Results for the Fiscal Year Ending March 2026 (Japanese GAAP) | Daicel Corporation (4202) timely disclosure | Komori